Ulcerative colitis Trials in Auckland, New Zealand
Conditions / Ulcerative colitis / Auckland, New Zealand
Research into Ulcerative colitis spans multiple therapeutic approaches and trial phases.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06052059 | A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001) | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00207688 | A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients | COMPLETED | — |
| NCT02520284 | Safety and Efficacy of Andecaliximab (GS-5745) in Adults With Moderately to Severely Active Ulcerative Colitis | TERMINATED | PHASE2/PHASE3 |
| NCT02118584 | Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies | TERMINATED | PHASE3 |
| NCT06290934 | Study of GS-1427 in Participants With Moderately to Severely Active Ulcerative Colitis | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT01458574 | A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01470612 | Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT00151892 | Efficacy and Safety of SPD476 in Maintaining Remission in Patients With Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT01458951 | A Study To Evaluate Both The Efficacy and Safety Profile of CP-690,550 In Patients With Moderately to Severely Active Ulcerative Colitis | COMPLETED | PHASE3 |
| NCT05782907 | Study to Assess Adverse Events, Change in Disease Activity, and How Oral Upadacitinib Moves Through the Body of Pediatric Participants With Moderately to Severely Active Ulcerative Colitis. | ACTIVE_NOT_RECRUITING | PHASE3 |